Abstract
Epidemiology is the study of distributions and determinants of diseases and their associated risk factors. Studies are typically based on large samples of individuals from the general healthy population and/or samples of disease cases from the same or a similar population. Molecular epidemiology is a relatively new discipline in epidemiology dealing with patterns of molecular risk factors of complex diseases. The investigation of broad panels of molecular intermediate phenotypes is central as they may provide a direct access to the underlying disease causing mechanisms. Genetically determined molecular phenotypes are typically quantitative traits that are known to be risk factors for complex diseases and they are assumed to be modulated by common genetic variants. Metabolite concentrations are examples of such genetically determined molecular phenotypes which we call genetically determined metabotypes. In contrast, genetic epidemiology means different things to different people. We regard it as a discipline that focuses on the familial, and in particular genetic, determinants of complex disease and investigates the joint effects of genes and non-genetic determinants such as environmental factors, lifestyles and diets. Both in molecular and genetic epidemiology appropriate account has to be taken regarding the biology that underlies the action of genes and the known mechanisms of inheritance. Important aspects in epidemiology are appropriate study design, data collection, data quality control, statistical analysis, as well as interpretation of results. In this chapter we will discuss some of these issues with a particular focus on genetic association studies in the general population or in case-control studies.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Sebat J, Lakshmi B, Malhotra D et al (2007) Strong association of de novo copy number mutations with autism. Science 316(5823):445–449
Stefansson H, Ophoff RA, Steinberg S et al (2009) Common variants conferring risk of schizophrenia. Nature 460(7256):744–747
The International Schizophrenia Consortium (2008) Rare chromosomal deletions and duplications increase risk of schizophrenia. Nature 455(7210):237–241
Jacquemont S, Reymond A, Zufferey F et al (2011) Mirror extreme BMI phenotypes associated with gene dosage at the chromosome 16p11.2 locus. Nature 478:97–102
The Wellcome Trust Case Control Consortium (2010) Genome-wide association study of CNVs in 16,000 cases of eight common diseases and 3,000 shared controls. Nature 464(7289):713–720
Barrett JC, Fry B, Maller J, Daly M (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21(2):263–265
Stephens M, Smith NJ, Donnelly P (2001) A new statistical method for haplotype reconstruction from population data. Am J Hum Genet 68(4):978–989
Scheet P, Stephens M (2006) A fast and flexible statistical model for large-scale population genotype data: applications to inferring missing genotypes and haplotypic phase. Am J Hum Genet 78(4):629–644
Lewontin RC (1964) The interaction of selection and linkage. I. General considerations; heterotic models. Genetics 49(1):49–67
Moskvina V, Craddock N, Holmans P et al (2006) Effects of differential genotyping error rate on the type I error probability of case-control studies. Hum Hered 61(1):55–64
Weir BS (1996) Genetic data analysis 2: methods for discrete population genetic data. Sinauer, Sunderland
Agresti A (2002) Categorical data analysis. (Wiley series in probability and statistics). Wiley-Interscience, Indianapolis
Ziegler A, König IR (2006) A statistical approach to genetic epidemiology: concepts and applications. Wiley-VCH, Indianapolis
Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc Ser B Methodological 57:289–300
Storey J, Tibshirani R (2003) Statistical significance for genome-wide studies. Proc Natl Acad Sci 100:9440–9445
Storey JD (2002) A direct approach to false discovery rates. J Roy Stat Soc Ser B 64:479–498
Dehghan A, Dupius J, Barbalic M et al (2011) Meta-analysis of genome-wide association studies in >80,000 subjects identifies multiple loci for C-reactive protein levels. Circulation 123(7):731–738
Marzi C, Albrecht E, Hysi PG et al (2010) Genome-wide association study identifies two novel regions at 11p15.5-p13 and 1p31 with major impact on acute-phase serum amyloid A. PLoS Genet 6(11):e1001213
Caulfield MJ, Munroe PB, O’Neill D et al (2008) SLC2A9 is a high-capacity urate transporter in humans. PLoS Med 5(10):e197
Vitart V, Rudan I, Hayward C et al (2008) SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 40(4):437–442
Hirschhorn JN (2009) Genomewide association studies–illuminating biologic pathways. N Engl J Med 360(17):1699–1701
Teslovich TM, Musunuru K, Smith AV et al (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466(7307):707–713
Hindorff LA, Sethupathy P, Junkins HA et al (2009) Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci USA 106(23):9362–9367
Hardy J, Singleton A (2009) Genomewide association studies and human disease. N Engl J Med 360(17):1759–1768
Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn K (2002) A comprehensive review of genetic association studies. Genet Med 4(2):45–61
Pe’er I, Yelensky R, Altshuler D, Daly MJ (2008) Estimation of the multiple testing burden for genomewide association studies of nearly all common variants. Genet Epidemiol 32(4):381–385
Marchini J, Donnelly P, Cardon LR (2005) Genome-wide strategies for detecting multiple loci that influence complex diseases. Nat Genet 37(4):413–417
Li Y, Willer CJ, Ding J, Scheet P, Abecasis GR (2010) MaCH: using sequence and genotype data to estimate haplotypes and unobserved genotypes. Genet Epidemiol 34(8):816–834
de Bakker PI, Ferreira MAR, Jia X et al (2008) Practical aspects of imputation-driven meta-analysis of genome-wide association studies. Hum Mol Genet 17(R2):R122–R128
Zeggini E, Ioannidis JP (2009) Meta-analysis in genome-wide association studies. Pharmacogenomics 10(2):191–201
Voight BF, Scott LJ, Steinthorsdottir V et al (2010) Twelve type 2 diabetes susceptibility loci identified through large-scale association analysis. Nat Genet 42(7):579–589
Schunkert H, Köning IR, Kathiresan S et al (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 43(4):333–338
Lango Allen H, Estrada K, Lettre G et al (2010) Hundreds of variants clustered in genomic loci and biological pathways affect human height. Nature 467(7317):832–838
Ehret GB, Munroe PB, Rice KM et al (2011) Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature 478(7367):103–109
Ioannidis JP, Patsopoulos NA, Evangelou E (2007) Uncertainty in heterogeneity estimates in meta-analyses. BMJ 335(7626):914–916
Campbell CD, Ogburn EL, Lunetta KL et al (2005) Demonstrating stratification in a European American population. Nat Genet 237(8):868–872
Price AL, Patterson NJ, Plenge RM et al (2006) Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet 38(8):904–909
Bacanu SA, Devlin B, Roeder K (2002) Association studies for quantitative traits in structured populations. Genet Epidemiol 22(1):78–93
Bacanu SA, Devlin B, Roeder K (2000) The power of genomic control. Am J Hum Genet 66(6):1933–1944
Devlin B, Roeder K (1999) Genomic control for association studies. Biometrics 55(4):997–1004
Kolz M, Johnson T, Sanna S et al (2009) Meta-analysis of 28,141 individuals identifies common variants within five new loci that influence uric acid concentrations. PLoS Genet 5(6):e1000504
Döring A, Christian G, Mehta D et al (2008) SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 40(4):430–436
Yang Q, Köttgen A, Dehghan A et al (2010) Multiple genetic loci influence serum urate levels and their relationship with gout and cardiovascular disease risk factors. Circ Cardiovasc Genet 3(6):523–530
Woodward OM, Köttgen A, Coresh J et al (2009) Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout. Proc Natl Acad Sci USA 106(25):10338–10342
Manolio TA, Collins FS, Cox NJ et al (2009) Finding the missing heritability of complex diseases. Nature 461(7265):747–753
McCarthy MI, Abecasis GR, Cardon LR et al (2008) Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet 9(5):356–369
Park JH, Wacholder S, Gail MH et al (2010) Estimation of effect size distribution from genome-wide association studies and implications for future discoveries. Nat Genet 42(7):570–575
Yang J, Manolio TA, Pasquale LR et al (2011) Genome partitioning of genetic variation for complex traits using common SNPs. Nat Genet 43(6):519–525
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2012 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Gieger, C. (2012). Statistical Methods in Genetic and Molecular Epidemiology and Their Application in Studies with Metabolic Phenotypes. In: Suhre, K. (eds) Genetics Meets Metabolomics. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1689-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-4614-1689-0_4
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-1688-3
Online ISBN: 978-1-4614-1689-0
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)